It could serve as a biomarker to independently forecast the prognostic outcomes of ccRCC patients, and was positively associated with the expression signatures of various immune cells (memory B cell, NK cell and Th1 cell) and ICI genes (ADORA2A, CD200, CD44) (42). This evidence concerns the gene CD44 and nonpapillary renal cell carcinoma.